- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04499066
Peripartum Mental Health Cohort Study in Guangzhou
September 11, 2023 updated by: Xiu Qiu, Guangzhou Women and Children's Medical Center
The purpose of this study is to determine the incidence,development trajectory and risk factors of the main peripartum mental health problems as well as explore its adverse outcomes.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Peripartum mental health problems (such as anxiety and depression), affecting more than 20% of mothers, is one of the most common complications around childbirth and gradually have become global public health issues.
However, little is known about the course of peripartum mental health problems and possible fluctuations, as well as related risk factors among Chinese women.
In addition, there are no effective prediction and preventive strategies for postpartum depression.
The Peripartum Mental Health Cohort Study in Guangzhou will collect the epidemiological, clinical information and biological specimens across pregnancy and childbirth to establish trajectory of peripartum mental health and identify the factors influencing the fluctuations and build a comprehensive prediction model of postpartum depression, as well as explore its adverse outcomes.
This study would help to determine the timing of screening and target interventions to improve women's and their offspring's health.
Study Type
Observational
Enrollment (Estimated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiu Qiu, PhD
- Phone Number: 0086 20 38367160
- Email: qxiu0161@163.com
Study Contact Backup
- Name: Dongmei Wei, MSc
- Phone Number: 0086 20 38367159
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510623
- Recruiting
- Guangzhou Women And Children's Medical Center
-
Contact:
- Xiu Qiu, PhD
- Email: qxiu0161@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Pregnant women before 20 weeks of gestation
Description
Inclusion Criteria:
- Pregnant women with <20 weeks of gestation
- Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center
- Permanent residents or families intended to remain in Guangzhou with their child for more than 3 years
Exclusion Criteria:
- Combined with heart disease, hypertension, diabetes or hyperthyroidism
- Taking anti-depressants and other treatments for depression
- Participants was in infection status when the biological samples were collected
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of prevalence of maternal prenatal depression
Time Frame: before 20th gestational week, after 33th gestational week and prior to delivery
|
Using Self-rating Depression Scale (SDS) to assess maternal depressive symptoms during pregnancy.
SDS scores ≥53 is defined as prenatal depressive symptoms.
|
before 20th gestational week, after 33th gestational week and prior to delivery
|
Change of prevalence of maternal postpartum depression in the first year after delivery
Time Frame: 6 weeks, 6 months and 1 year after delivery
|
Using Edinburgh Postnatal Depression Scale (EPDS) to assess postpartum depressive symptoms.
EPDS scores ≥13 is defined as postpartum depressive symptoms.
|
6 weeks, 6 months and 1 year after delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of prevalence of maternal anxiety during pregnancy
Time Frame: before 20th gestational week, after 33th gestational week and prior to delivery
|
Using Self-rating Anxiety Scale (SAS) to assess maternal anxiety during pregnancy.
SAS scores ≥50 is defined as anxiety.
|
before 20th gestational week, after 33th gestational week and prior to delivery
|
Level of maternal cortisol during pregnancy
Time Frame: During period of 2-3 trimesters of pregnancy
|
Using women's blood samples to test the concentration of cortisol.
|
During period of 2-3 trimesters of pregnancy
|
Levels of maternal inflammatory factors during pregnancy
Time Frame: During period of 2-3 trimesters of pregnancy
|
Using women's blood samples to test the concentration of inflammatory factors, including CRP, IL-6, TNF-α, etc.
|
During period of 2-3 trimesters of pregnancy
|
Prevalence of preterm birth, small for gestational age, low birth weight
Time Frame: At delivery
|
Obtained from electronic medical records.
|
At delivery
|
Child's neurodevelopment at early childhood
Time Frame: At child's age of 1 year
|
Assessed by using the Gesell Developmental Schedules, which includes adaptive, gross motor, fine motor, language, and social function domains.
Higher score in each domain is considered a better outcome, while no more than 85 is defined as suspected development delay.
|
At child's age of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Xiu Qiu, PhD, Guangzhou Women And Children's Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2012
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2038
Study Registration Dates
First Submitted
July 21, 2020
First Submitted That Met QC Criteria
July 30, 2020
First Posted (Actual)
August 5, 2020
Study Record Updates
Last Update Posted (Actual)
September 13, 2023
Last Update Submitted That Met QC Criteria
September 11, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018053101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States